Form 4: MIRA Pharmaceuticals Director Brian McNulty Sells 200,000 Shares, Updates Power of Attorney

Brian McNulty, a director and 10% owner of MIRA Pharmaceuticals, sold 200,000 shares of common stock at $1.96 per share and updated his power of attorney.

Summary

• Brian McNulty, a director and 10% owner of MIRA Pharmaceuticals, sold 200,000 shares of common stock on August 28, 2024, at a price of $1.96 per share.
• Following the transaction, McNulty directly owns 10,000 shares and indirectly owns 2,540,270 shares through a trust.
• McNulty also updated his power of attorney, appointing Michelle Yanez to execute and file Forms 3, 4, and 5 on his behalf in accordance with Section 16(a) of the Securities Exchange Act of 1934.
• The power of attorney grants Yanez the authority to obtain information on transactions in the company's securities from third parties and to take any action in connection with the foregoing that may be of benefit to, in the best interest of, or legally required by McNulty.

Sentiment

Score: 5

Explanation: The sentiment is neutral. It reflects a routine transaction (share sale) and an administrative update (power of attorney). The share sale could be viewed negatively, but without further context, it's difficult to assess the overall impact.

Negatives

• A director selling a significant number of shares could be interpreted negatively by the market.

Risks

• The sale of shares by a director could create uncertainty among investors.
• Reliance on a power of attorney for SEC filings introduces a potential point of failure if the attorney-in-fact is unable to fulfill their responsibilities.

Industry Context

Sales of shares by company insiders are a common occurrence, and investors often monitor these transactions to gauge management's sentiment about the company's prospects. A power of attorney is a standard legal document used to delegate responsibilities.

Comparison to Industry Standards

• Insider sales are a common occurrence in publicly traded companies.
• The reporting requirements under Section 16 of the Securities Exchange Act are standard practice for directors and officers.
• Power of attorney arrangements for SEC filings are not uncommon, especially for busy executives.

Stakeholder Impact

• Shareholders may react to the director's sale of shares, potentially impacting the stock price.
• The updated power of attorney ensures continued compliance with SEC regulations.

Key Dates